Status:
ENROLLING_BY_INVITATION
Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
San Francisco Veterans Affairs Medical Center
Conditions:
Immunosuppresion
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this wait-list control trial is to learn if having access to a new dashboard displaying information about immunosuppressed Veterans missing vaccinations for Shingrix can improve Shingrix v...
Detailed Description
Assignment of the intervention will occur at the facility level. Outcomes (vaccination) will be assessed for patients cared for at each facility.
Eligibility Criteria
Inclusion
- In order to be included in the study, clinicians need to work at a VHA facility and have access to the electronic health record.
Exclusion
- None.
Key Trial Info
Start Date :
September 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06596148
Start Date
September 16 2024
End Date
June 30 2026
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco VA
San Francisco, California, United States, 94121